Swedish Brain Power dominate Lancet report on dementia

15 Mar 2016

cov200hThe Lancet Neurology dedicates its latest issue to Alzheimer’s and other dementias. The renowned scientific journal has given the Swedish Brain Power’s director Professor Bengt Winblad the task of leading a commission of experts in order to provide recommendations to policy and decision makers on how the fight against dementia should be organized in the future. The work is presented to the European Parliament in Brussels today.


– What we need now is for the politicians to realise that this is a growing problem that already cost society tremendous amounts of money. We need investments of resources in research in all areas involved in this disease, to find better drugs, but also improve compassionate care and prevention, says Bengt Winblad.


The comission includes more than 30 leading international researchers, of which over a third is linked to the Swedish Brain Power network. The result, a 78 pages long report, is the entire content of the April issue of The Lancet Neurology. It addresses a wide range of actions in health economics, epidemiology, prevention, genetics, biology, diagnosis, treatment, care and ethics. The expert group identify a range of challanges and advocates that public governmental agencies form large multinational parnerships with academic centers an pharmaceutical companies to deploy capital resources and share risks.


– To defeat Alzheimer’s disease and other dementias, united actions are needed, not only within research, but also within the political arena on all levels. My hope is that our work will stimulate increased national and international collaboration, says Bengt Winblad.


Alzheimer’s is the most common form of dementia, accounting for about 60 percent of cases. The main risk factor is old age. As life expectancy increases it’s estimated that the number of people with dementia will rise dramatically as long as one does not find any treatment that can slow down or stop the disease. Today almost 47 million people worldwide are estimated to be affected. By 2030, the number is expected to reach 75 million and by 2050 as many as 131 million people may be affected.


The Lancet Neurology Commission paper is av work by researchers from Sweden, France, Britain, Australia, Denmark, Canada, Switzerland, Italy, Luxembourg, the US, Germany and the Netherlands.


The Swedish Brain Power researchers, besides Bengt Winblad, who has contributed to the report are Angel Cedazo-Minguez, Laura Fratiglioni, Caroline Graff, Gunilla Johansson, Linus Jönsson, Miia Kivipelto, Agneta Nordberg, Chengxuan Qui, Lars O Tjernberg, Anders Wimo and Henrik Zetterberg.


The comissions report will be presented to the European Parliament in Brussels 15 mars in connection with the ongoing international Brain Awareness Week 2016.


Read The Lancet Neurology Commission paper here.


For questions, please contact:

Bengt Winblad, professor of geriatrics

Department of Neurobiology, Care Sciences and Society

Center for Alzheimer’s Research

Phone: +46 70-632 67 71


© 2010 Swedish Brain Power